Core Insights - The flagship project of China Biotech Services, the Pengbo (Hainan) Boron Neutron Hospital, has achieved a significant milestone by successfully achieving the first neutron beam output from its NeuCure® neutron irradiation system, marking a critical advancement in the project timeline [1] Company Developments - The hospital is located in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan, which provides supportive policy advantages for its operations [1] - The NeuCure® system is the only boron neutron therapy system globally that has received formal medical device registration and can be applied directly in routine clinical treatment, rather than being limited to clinical trials [1] - Clinical treatment services using this system are expected to officially commence in the first quarter of 2026 [1] Project Progress - The successful beam output confirms that the core components of the system meet the design specifications, transitioning the project from equipment installation to beam commissioning [1] - This milestone lays a solid foundation for subsequent critical tasks, including precise neutron dose rate control, beam physics validation, and biological effect assessment [1] - The advancement ensures that the equipment can proceed with high standards in clinical treatment, providing safe and precise boron neutron therapy services for cancer patients [1]